FDA inspection
Linda D. Bosserman: FDA inspection ending Dec 22, 2010
FDA inspection 703028 · Official Action Indicated (OAI) · La Verne, CA
Key facts
| Inspection ID | 703028 |
|---|---|
| Firm | Linda D. Bosserman |
| FEI number | 3008480759 |
| Address | Wilshire Oncology Medical Group, Inc., 1502 Arrow Hwy |
| City | La Verne |
| State | CA |
| ZIP | 91750 |
| Country | United States |
| Fiscal year | 2011 |
| Inspection end date | Dec 22, 2010 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 190013 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data